Archive · 24 Jul 2025
Senores Pharma Share Price Surges After Strong Q1 Financials
Senores Pharma, a medicine company, had a great quarter!
Their stock price went up a lot.
They made more money than last year, with revenue and profit increasing significantly.
The company also launched new products and got approvals for more.
The share price has doubled in value since its IPO, meaning investors have made a lot of money.
The company's success is also attributed to its ability to sell to both government and retail customers in the US.
Senores Pharma's share price rose 13% after strong Q1 results.
The stock reached a record high during Thursday's trading.
Revenue grew 72% year-on-year to ₹137.99 crore.
Net profit increased 94% YoY to ₹21.18 crore.
The company's stock has doubled allottees' money in seven months.
- Who
- Senores Pharma.
- What
- Senores Pharma's share price increased due to strong financial results.
- When
- The share price increase was reported during Thursday's trading session after the Q1 results ending June 30, 2025.
- Where
- The company operates in the pharmaceutical market, with a focus on regulated and emerging markets.
- Why
- The share price increased due to a sharp rise in revenue and net profit reported in the Q1 results.
- Share Price Increase
- 13%
- Trading Price
- ₹686 apiece
- Revenue (YoY)
- 72%
- Net Profit (YoY)
- 94%
- EBITDA (YoY)
- 60%
- IPO Price
- ₹391